v3.25.1
Note 2 - Significant Accounting Policies - Schedule of Earnings Per Share (Details) - USD ($)
 12 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Net loss [1] $ (10,159,000) $ (18,697,000)
Basic and Diluted Earnings Per Share (in dollars per share) $ (2.53) $ (4.96)
Diluted net loss per share of common stock (in dollars per share) [1] $ (2.53) $ (4.96)
Weighted average number of common shares – basic and diluted (in shares) [1] 4,008,846 3,767,361
Effect of dilutive securities – Stock options and Restricted stock (2) (in shares) [2] 0 0
Weighted average shares outstanding – Diluted (in shares) 4,008,846 3,767,361
[1] Excludes the effect of unvested restricted shares of common stock, which are considered non-participating securities. As of January 31, 2025 and 2024, there were 213,273 and 131,350 unvested restricted shares of common stock, respectively.
[2] Diluted net loss per share excludes the effect of shares that are anti-dilutive. As of January 31, 2025, there were 3,630 outstanding stock options and 213,273 unvested restricted shares of common stock. As of January 31, 2024, there were 4,496 outstanding stock options and 131,350 unvested restricted shares of common stock.